Johnson & Johnson (JNJ) Restructuring Costs (2010 - 2026)

Johnson & Johnson has disclosed Restructuring Costs across 14 years of filings, most recently posting $32.0 million for Q1 2026.

• Restructuring Costs for Q1 2026 came in at $32.0 million, up 88.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $243.0 million (up 179.31% YoY), and the FY2025 annual result was $228.0 million, down 2.56% from the prior year.
• Restructuring Costs came in at $32.0 million for Q1 2026 at Johnson & Johnson, down from $84.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $164.0 million in Q1 2024 to a low of -$13.0 million in Q2 2024.
• The 5-year median for Restructuring Costs is $65.0 million (2022), against an average of $77.0 million.
• Across the five-year window, Restructuring Costs tumbled 108.97% in 2024 and jumped 592.31% in 2025, its largest moves.
• Johnson & Johnson's Restructuring Costs stood at $65.0 million in 2022, then retreated by 13.85% to $56.0 million in 2023, then declined by 25.0% to $42.0 million in 2024, then soared by 100.0% to $84.0 million in 2025, then plunged by 61.9% to $32.0 million in 2026.
• The last three Restructuring Costs figures came in at $32.0 million (Q1 2026), $84.0 million (Q4 2025), and $63.0 million (Q3 2025), per Business Quant data.